Â¥
3.38
Jan 15
New Key Statistics Module, Z-Score and F-Score
SZSE:300110 Key Ratios
Market Cap ¥ M | 3,995.88 |
Enterprise Value ¥ M | 5,598.79 |
P/E(ttm) | 27.26 |
PE Ratio without NRI | 28.89 |
Forward PE Ratio | -- |
Price/Book | 1.44 |
Price/Sales | 2.67 |
Price/Free Cash Flow | 11.17 |
Price/Owner Earnings | 37.55 |
Payout Ratio % | 0.18 |
Revenue (TTM) ¥ M | 1,493.00 |
EPS (TTM) ¥ | 0.12 |
Beneish M-Score | -2.55 |
10-y EBITDA Growth Rate % | 6.60 |
5-y EBITDA Growth Rate % | 19.10 |
y-y EBITDA Growth Rate % | -11.60 |
EV-to-EBIT | 23.09 |
EV-to-EBITDA | 23.09 |
PEG | 1.51 |
Shares Outstanding M | 1,182.21 |
Net Margin (%) | 9.81 |
Operating Margin % | 15.41 |
Pre-tax Margin (%) | 12.57 |
Quick Ratio | 1.56 |
Current Ratio | 1.78 |
ROA % (ttm) | 2.91 |
ROE % (ttm) | 5.39 |
ROIC % (ttm) | 4.20 |
Dividend Yield % | 0.61 |
Altman Z-Score | 2.17 |
SZSE:300110 Number of Guru Trades
SZSE:300110 Volume of Guru Trades
Gurus Latest Trades with SZSE:300110
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300110 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Huaren Pharmaceutical Co Ltd Insider Transactions
No Available Data